John Fullarton, n/a

Violicom Medical Limited, United Kingdom

Disclosure(s): AstraZeneca: Employer has received payment from AstraZeneca for work on various projects outside the scope of this study; Sanofi: Employer has received payment from Sanofi for work on various projects outside the scope of this study

Poster(s):

• (P-1282) Saving Lives and Costs: Respiratory Syncytial Virus Wastewater Surveillance to Guide all infant prophylaxis in Ontario, Canada
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-2338) Global surveillance of human Metapneumovirus (hMPV) and Respiratory Syncytial Virus (RSV) epidemiology since 2022
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT